Home>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>AG-490 (Tyrphostin B42)

AG-490 (Tyrphostin B42) Sale

(Synonyms: 酪氨酸磷酸化抑制剂AG490) 目录号 : GC13854

AG-490是EGFR抑制剂,IC50为0.1 µM, AG-490对JAK2也有抑制作用。.

AG-490 (Tyrphostin B42) Chemical Structure

Cas No.:133550-30-8

规格 价格 库存 购买数量
10mg
¥284.00
现货
25mg
¥494.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

客户使用产品发表文献 2

产品文档

Quality Control & SDS

View current batch:

实验参考方法

Cell experiment [1]:

Cell lines

RAW264.7 cell

Preparation Method

Cells were cultured in the presence of RANKL (100 ng/mL) and increasing concentrations of AG-490.

Reaction Conditions

5-50 µM;3days

Applications

AG-490 suppresses RANKL-induced osteoclastogenesis in RAW264.7 cells.

Animal experiment [2]:

Animal models

Female B6C3F1 mice(HM-1 cancer model)

Preparation Method

Mice were daily treated with an intraperitoneal injection of AG-490 (500µg /mouse) or PBS alone as the control.

Dosage form

500 µg/mouse; i.p;11days

Applications

AG-490 treatment significantly suppressed subcutaneous tumor growth compared with control.

References:

[1]. Li CH, Zhao JX, et,al. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis. Biochem Biophys Res Commun. 2013 Jun 14;435(4):533-9. doi: 10.1016/j.bbrc.2013.04.084. Epub 2013 May 7. PMID: 23665018.
[2]. Kobayashi A, Tanizaki Y, et,al. AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer. Eur J Pharmacol. 2015 Nov 5;766:63-75. doi: 10.1016/j.ejphar.2015.09.039. Epub 2015 Sep 26. PMID: 26410360.

产品描述

AG-490 (Tyrphostin B42) is EGFR inhibitor with IC50 of 0.1 µM, AG-490 also has an inhibitory effect on JAK2[1-3].

AG-490(5-50 µM;3days) suppresses RANKL-induced osteoclastogenesis in RAW264.7 cells[4]. AG490(20 µM; 4 h) inhibits hOAT3 transport activity[5]. AG-490(10 µM)suppresses interleukin-34-mediated osteoclastogenesis in mice bone marrow macrophages[6].

AG-490(5-15 µM;i.p;) exerted protection effects by preventing the neural apoptosis in vivo[7]. In tumor mice, AG-490(500 µg/mouse;i.p;11days) treatment significantly inhibited subcutaneous tumor growth[8].

References:
[1]. DuhÉ RJ, Clark EA, et,al. Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein. Mol Cell Biochem. 2002 Jul;236(1-2):23-35. doi: 10.1023/a:1016186907376. PMID: 12190118.
[2]. Luo C, Laaja P. Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs. Drug Discov Today. 2004 Mar 15;9(6):268-75. doi: 10.1016/S1359-6446(03)03014-9. PMID: 15003245.
[3]. Gazit A, Osherov N, et,al. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J Med Chem. 1991 Jun;34(6):1896-907. doi: 10.1021/jm00110a022. PMID: 1676428.
[4]. Li CH, Zhao JX, et,al. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis. Biochem Biophys Res Commun. 2013 Jun 14;435(4):533-9. doi: 10.1016/j.bbrc.2013.04.084. Epub 2013 May 7. PMID: 23665018.
[5]. Zhang J, Liu C, et,al. AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3. J Pharmacol Sci. 2018 Mar;136(3):142-148. doi: 10.1016/j.jphs.2018.01.006. Epub 2018 Feb 8. PMID: 29487013; PMCID: PMC7863619.
[6]. Cheng X, Wan QL, et,al. AG490 suppresses interleukin-34-mediated osteoclastogenesis in mice bone marrow macrophages. Cell Biol Int. 2017 Jun;41(6):659-668. doi: 10.1002/cbin.10771. Epub 2017 Apr 19. PMID: 28378938.
[7]. Fan L, Zhou L. AG490 protects cerebral ischemia/reperfusion injury via inhibiting the JAK2/3 signaling pathway. Brain Behav. 2021 Jan;11(1):e01911. doi: 10.1002/brb3.1911. Epub 2020 Oct 23. PMID: 33098244; PMCID: PMC7821583.
[8]. Kobayashi A, Tanizaki Y, et,al. AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer. Eur J Pharmacol. 2015 Nov 5;766:63-75. doi: 10.1016/j.ejphar.2015.09.039. Epub 2015 Sep 26. PMID: 26410360.

AG-490 (Tyrphostin B42)是EGFR抑制剂,IC50为0.1 µM, AG-490对JAK2也有抑制作用[1-3]。

AG-490 (5-50 µM;3days)抑制RANKL诱导的RAW264.7细胞破骨生成[4]。AG-490(20µM;4 h)抑制hOAT3转运活性[5]。AG-490(10µM)抑制白细胞介素-34介导的小鼠骨髓巨噬细胞破骨生成[6]。

AG-490(5-15 µM;i.p)在体内通过阻止神经细胞凋亡发挥保护作用[7]。在肿瘤小鼠中,AG-490 (500 µg/mouse;i.p;11days)治疗可显著抑制皮下肿瘤生长[8]。

Chemical Properties

Cas No. 133550-30-8 SDF
别名 酪氨酸磷酸化抑制剂AG490
化学名 (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide
Canonical SMILES C1=CC=C(C=C1)CNC(=O)C(=CC2=CC(=C(C=C2)O)O)C#N
分子式 C17H14N2O3 分子量 294.3
溶解度 Soluble in DMSO > 10 mM 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.3979 mL 16.9895 mL 33.9789 mL
5 mM 0.6796 mL 3.3979 mL 6.7958 mL
10 mM 0.3398 mL 1.6989 mL 3.3979 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置